Outcome of neoadjuvant chemotherapy in “locally advanced/borderline resectable” gallbladder cancer: the need to define indications-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcome of neoadjuvant chemotherapy in “locally advanced/borderline resectable” gallbladder cancer: the need to define indications

Published:2018-09 Issue:9 Volume:20 Page:841-847
ISSN:1365-182X
Container-title:HPB
language:en
Short-container-title:HPB

Author:

Chaudhari Vikram A.,Ostwal Vikas,Patkar Shraddha,Sahu Arvind,Toshniwal Anup,Ramaswamy Anant,Shetty Nitin S.,Shrikhande Shailesh V.,Goel Mahesh

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference21 articles.

1. Epidemiology and molecular pathology of gallbladder cancer;Lazcano-Ponce;CA A Cancer J Clin,2001

2. Towards an oncological resection of gall bladder cancer;Boerma;Eur J Surg Oncol,1994

3. Gemcitabine and cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder;Malik;Am J Clin Oncol,2003

4. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis;Horgan;J Clin Oncol,2012

5. Adjuvant therapy in the treatment of gallbladder cancer: a meta-analysis;Ma;BMC Cancer,2015

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chinese national clinical practice guideline on diagnosis and treatment of biliary tract cancers;Chinese Medical Journal;2024-09-04

2. Analysis of neoadjuvant therapy effect on 30-day postoperative outcomes in gallbladder cancer;Surgery Open Science;2024-09

3. Comparison of age-stratified survival outcomes of gallbladder cancers in an Indian population;HPB;2024-09

4. How I Manage My Patients with Gall Bladder Cancer?;Indian Journal of Surgical Oncology;2024-07-30

5. Gallbladder cancer (GBC) with Retroperitoneal Lymphadenopathy (RPLN) have outcomes similar to locally advanced disease if treated with radical intent.;2024-07-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3